Galderma Granted Key Manufacturing License Updates for New Biologics Capabilities at Its Center of Excellence
The Swedish Medical Products Agency has issued a license update authorizing the future manufacture and bioanalytical testing of Galderma’s proprietary investigational ready-to-use liquid botulinum toxin A, RelabotulinumtoxinA This further establishes Galderma’





